Cambrex to buy pharmaceutical services company Halo for $425m
Life sciences company Cambrex has signed a definitive agreement to purchase pharmaceutical services provider Halo Pharma for approximately $425m. Halo…
Life sciences company Cambrex has signed a definitive agreement to purchase pharmaceutical services provider Halo Pharma for approximately $425m. Halo…